Indicators of cure for women living after uterine and ovarian cancers: a population-based study

被引：3

作者：

Giudici, Fabiola ^{[1
]}

De Paoli, Angela

Toffolutti, Federica ^{[1
]}

Guzzinati, Stefano ^{[2
]}

Francisci, Silvia ^{[3
]}

Bucchi, Lauro ^{[4
]}

Gatta, Gemma ^{[5
]}

Demuru, Elena ^{[6
]}

Mallone, Sandra ^{[3
]}

Cin, Antonella Dal ^{[2
]}

Caldarella, Adele ^{[7
]}

Cuccaro, Francesco ^{[8
]}

Migliore, Enrica ^{[9
,10
]}

Gambino, Maria Letizia ^{[11
]}

Ravaioli, Alessandra ^{[4
]}

Puppo, Antonella ^{[12
]}

Ferrante, Margherita ^{[13
]}

Carrozzi, Giuliano ^{[14
]}

Stracci, Fabrizio ^{[15
]}

Musolino, Antonino ^{[16
]}

Gasparotti, Cinzia ^{[17
]}

Cavallo, Rossella ^{[18
]}

Mazzucco, Walter ^{[19
]}

Vitale, Maria Francesca ^{[20
]}

Cascone, Giuseppe ^{[21
,27
]}

Ballotari, Paola ^{[22
]}

Ferretti, Stefano ^{[23
,24
]}

Mangone, Lucia ^{[25
]}

Rizzello, Roberto Vito ^{[26
]}

Sampietro, Giuseppe

Mian, Michael ^{[28
]}

Boschetti, Lorenza ^{[29
]}

Galasso, Rocco ^{[30
]}

Bella, Francesca ^{[31
]}

Piras, Daniela ^{[32
]}

Sessa, Alessandra ^{[33
]}

Seghini, Pietro ^{[34
]}

Fanetti, Anna Clara ^{[35
]}

Pinna, Pasquala ^{[36
]}

De Angelis, Roberta

Serraino, Diego ^{[1
]}

Dal Maso, Luigino ^{[1
]}

机构：

[1] Ctr Riferimento Oncol Aviano CRO IRCCS, Canc Epidemiol Unit, Via Franco Gallini 2, I-33081 Aviano, Italy

[2] Azienda Zero, Epidemiol Dept, Padua, Italy

[3] Natl Inst Hlth, Natl Ctr Dis Prevent & Hlth Promot, I-00161 Rome, Italy

[4] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amador, Romagna Unit, Emilia Romagna Canc Registry, I-47121 Meldola, Forli, Italy

[5] Fdn IRCCS Ist Nazl Tumori Milano, Dept Res, Evaluat Epidemiol Unit, I-20133 Milan, Italy

[6] Natl Inst Hlth, Dept Oncol & Mol Med, I-00161 Rome, Italy

[7] Inst Canc Res Prevent & Clin Network, Tuscany Canc Registry, I-50139 Florence, Italy

[8] Local Hlth Unit Barletta Andria Trani, Sect Canc Registry Puglia, Sect Canc Registry Puglia, I-76121 Barletta, Italy

[9] Ctr Riferimento Epidemiol & Prevenz Oncolog CPO Pi, Piedmont Canc Registry, I-10123 Turin, Italy

[10] Univ Turin, I-10123 Turin, Italy

[11] SS Epidemiol Registri Specializzati & Reti Patol, Registro Tumori ATS Insubria Prov Como & Varese, I-21100 Varese, Italy

[12] IRCCS Osped Policlin San Martino, Liguria Canc Registry, I-16132 Genoa, Italy

[13] Igiene Ospedaliera, Azienda Ospedaliero Universitaria Policlin G Rodol, I-95123 Catania, Enna, Italy

[14] Local Hlth Author, Publ Hlth Dept, Modena Unit, Emilia Romagna Canc Registry, I-41126 Modena, Italy

[15] Univ Perugia, Dept Med & Surg, Publ Hlth Sect, Umbria Canc Registry, I-06123 Perugia, Italy

[16] Univ Hosp Parma, Parma Unit, Med Oncol Unit, Emilia Romagna Canc Registry, I-43126 Parma, Italy

[17] Registro Tumori ATS Brescia, Struttura Semplice Epidemiol, ATS Brescia, I-25124 Brescia, Italy

[18] Canc Registry Azienda Sanit Locale ASL Salerno, Dipartimento Prevenz, I-84124 Salerno, Italy

[19] Azienda Osped Univ Policlin AOUP Palermo, Clin Epidemiol & Canc Registry Unit, I-90127 Palermo, Italy

[20] Registro Tumori ASL Napoli 3 Sud, I-80031 Naples, Italy

[21] Azienda Sanit Provinciale ASP Ragusa, Dipartimento Prevenz, Registro Tumori, I-97100 Ragusa, Italy

[22] ATS Val Padana, Osservatorio Epidemiol, I-46100 Mantua, Italy

[23] Ferrara Unit, Emilia Romagna Canc Registry, Local Hlth Author, Ferrara, Italy

[24] Univ Ferrara, I-44121 Ferrara, Italy

[25] Azienda Un Sanit Locale IRCCS Reggio Emilia, Reggio Emilia Unit, Epidemiol Unit, Emilia Romagna Canc Registry, I-42122 Reggio Emilia, Italy

[26] Trento Prov Canc Registry, Unit Clin Epidemiol, I-38123 Trento, Italy

[27] Agenzia Tutela Salute, Bergamo Canc Registry, Epidemiol Serv, I-24121 Bergamo, Italy

[28] Lehrkrankenhaus Paracelsus Med Privatuniversitat, Innovat Res & Teaching Serv SABES ASDAA, I-39100 Bolzano, Italy

[29] Canc Registry Prov Pavia, I-27200 Pavia, Italy

[30] IRCCS Ctr Riferimento Oncol Basilicata CROB, Unit Reg Canc Registry, Clin Epidemiol & Biostat, I-85028 Rionero In Vulture, Italy

[31] Prov Hlth Author Siracusa, Siracusa Canc Registry, I-96100 Siracusa, Italy

[32] ASL, Nord Sardegna Canc Registry, I-07100 Sassari, Italy

[33] Monitoraggio Rischio Ambientale & Registro Tumori, I-81100 Caserta, Italy

[34] AUSL Piacenza, Publ Hlth Dept, Piacenza Unit, Emilia Romagna Canc Registry, I-29100 Piacenza, Italy

[35] Agenzia Tutela Salute Montagna, Sondrio Canc Registry, I-23100 Sondrio, Italy

[36] ASL Nuoro, Serv Igiene & San Pubbl, Nuoro Canc Registry, RT Nuoro, I-08100 Nuoro, Italy

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2024年 / 193卷 / 09期

关键词：

cure fraction; time to cure; cancer prevalence; ovarian cancer; cervical cancer; corpus uteri cancer; long-term survival; mixture cure models; CERVICAL-CANCER; EUROPE; 1999-2007; SURVIVAL; PROPORTION; PREVALENCE; PROGRAMS; SITES;

D O I：

10.1093/aje/kwae044

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

This study aims to estimate long-term survival, cancer prevalence, and several cure indicators for Italian women with gynecological cancers. Thirty-one cancer registries, representing 47% of the Italian female population, were included. Mixture cure models were used to estimate net survival, cure fraction, time to cure (when 5-year conditional net survival becomes > 95%), cure prevalence (women who will not die of cancer), and already cured (living longer than time to cure). In 2018, 0.4% (121 704) of Italian women were alive after diagnosis of corpus uteri cancer, 0.2% (52 551) after cervical cancer, and 0.2% (52 153) after ovarian cancer. More than 90% of patients with uterine cancers and 83% with ovarian cancer will not die from their neoplasm (cure prevalence). Women with gynecological cancers have a residual excess risk of death <5% at 5 years after diagnosis. The cure fraction was 69% for corpus uteri, 32% for ovarian, and 58% for cervical cancer patients. Time to cure was <= 10 years for women with gynecological cancers aged <55 years; 74% of patients with cervical cancer, 63% with corpus uteri cancer, and 55% with ovarian cancer were already cured. These results can contribute to improving follow-up programs for women with gynecological cancers and supporting efforts against discrimination of already cured ones. This article is part of a Special Collection on Gynecological Cancers.

引用

页码：1224 / 1232

页数：9

共 53 条

[51] Measuring population-level cure patterns for cancer patients in the United States [J].

Xia, Changfa ;

Yu, Xue Qin ;

Chen, Wanqing .

INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (04) :738-748

[52] Estimating the proportion cured of cancer: Some practical advice for users [J].

Yu, X. Q. ;

De Angelis, R. ;

Andersson, T. M. L. ;

Lambert, P. C. ;

O'Connell, D. L. ;

Dickman, P. W. .

CANCER EPIDEMIOLOGY, 2013, 37 (06) :836-842

[53] Screening patterns within organized programs and survival of Italian women with invasive cervical cancer [J].

Zucchetto, Antonella ;

Ronco, Guglielmo ;

Rossi, Paolo Giorgi ;

Zappa, Marco ;

Ferretti, Stefano ;

Franzo, Antonella ;

Falcini, Fabio ;

Visioli, Carmen Beatriz ;

Zanetti, Roberto ;

Biavati, Patrizia ;

La Rosa, Francesco ;

Baracco, Susanna ;

Federico, Massimo ;

Campari, Cinzia ;

De Togni, Aldo ;

Piffer, Silvano ;

Pannozzo, Fabio ;

Fusco, Mario ;

Michiara, Maria ;

Castaing, Marine ;

Seghini, Pietro ;

Tisano, Francesco ;

Serraino, Diego .

PREVENTIVE MEDICINE, 2013, 57 (03) :220-226

← 1 2 3 4 5 6 →